二甲双胍对胃癌合并2型糖尿病患者预后影响的Meta分析
《现代肿瘤医学》[ISSN:1672-4992/CN:61-1415/R]
- 期数:
- 2022年19期
- 页码:
- 3534-3538
- 栏目:
- 论著（消化肿瘤）
- 出版日期:
- 2022-08-30
文章信息/Info
- Title:
- Meta-analysis of the effect of metformin on the prognosis of patients with gastric cancer complicated with type 2 diabetes mellitus
- Author(s):
- CHEN Xiao; LIN Ru; CHEN Jixiang
- Department of Gastrointestinal Surgery,Affiliated Hospital of Jiangsu University，Jiangsu Zhenjiang 212001,China.
- Keywords:
- metformin; gastric cancer; type 2 diabetes mellitus; prognosis; Meta-analysis
- 分类号:
- R735.2
- DOI:
- 10.3969/j.issn.1672-4992.2022.19.017
- 文献标识码:
- A
- 摘要:
- 目的：系统评价二甲双胍对胃癌合并2型糖尿病患者预后的影响。方法：计算机检索Pubmed、Cochrane library、Embase、知网、万方、维普等数据库，由两名研究员根据纳入、排除标准分别对检索文献进行筛选、质量评价及数据提取。使用RevMan5.4软件对总体生存率、癌症特异性生存率、无复发生存率进行Meta分析，效应量为风险比（hazard ratio,HR），各效应量以95%置信区间（confidence interval,CI） 表示。结果：总共纳入10项研究，共计2 522例患者。Meta分析的结果显示，与未使用二甲双胍的患者相比，二甲双胍的使用能够提高胃癌合并2型糖尿病患者的总生存期（HR=0.71，95%CI：0.63~0.80，P＜0.000 01）、癌症特异性生存期（HR=0.76，95%CI：0.65~0.90，P=0.001）及无复发生存期（HR=0.58，95%CI：0.47~0.72，P＜0.000 01）。结论：与非二甲双胍治疗相比，接受二甲双胍治疗的胃癌合并2型糖尿病患者能够改善预后，总生存期、癌症特异性生存期及无复发生存期得到延长。
- Abstract:
- Objective：To systematically evaluate the effect of metformin on the prognosis of patients with gastric cancer complicated with type 2 diabetes mellitus.Methods：Pubmed，Cochrane library，Embase，CNKI，WAN FANG，VIP were searched by computer.The search data was from the establishment of the database to January 2021.According to the inclusion and exclusion criteria，two researchers screened，evaluated and extracted the data.The overall survival，cancer-specific survival and recurrence-free survival were analyzed by Meta using RevMan5.4.The effect was expressed by 95% confidence interval（95%CI） as risk ratio（HR）.Results：A total of 10 studies were included，with a total of 2 522 patients.The results of Meta-analysis showed that metformin could improve the overall survival（HR=0.71，95%CI：0.63~0.80，P＜0.000 01），cancer-specific survival（HR=0.76，95%CI：0.65~0.90，P=0.001） and recurrence-free survival（HR=0.58，95%CI：0.47~0.72，P＜0.000 01） in patients with gastric cancer complicated with type 2 diabetes compared with patients without metformin.Conclusion：Compared with non-metformin treatment，metformin-treated gastric cancer patients with type 2 diabetes can improve the prognosis and overall survival，cancer-specific survival and recurrence-free survival.
参考文献/References
[1]PRASHANTH RAWLA，BARSOUK ADAM．Epidemiology of gastric cancer：global trends，risk factors and prevention［J］．Przeglad Gastroenterologiczny，2019，14（1）：26-38．
[2]SHI YK，HU FRANK-B．The global implications of diabetes and cancer［J］．The Lancet（British edition），2014，383（9933）：1947-1948．
[3]CHIN-HSIAO TSENG．Diabetes and gastric cancer：The potential links［J］．World Journal of Gastroenterology，2014，20（7）：1701．
[4]FORETZ M，GUIGAS B，VIOLLET B．Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus［J］．Nat Rev Endocrinol，2019，15（10）：569-589.
[5]MARTA-K POWELL，CEMPIRKOVA DANA，DUNDR PAVEL，et al．Metformin treatment for diabetes mellitus correlates with progression and survival in colorectal carcinoma［J］．Translational Oncology，2020，13（2）：383-392．
[6]DONG YW，SHI YQ，HE LW，et al．Effects of metformin on survival outcomes of pancreatic cancer：a Meta-analysis［J］．Oncotarget,2017，8（33）：55478-55488.
[7]PAULA CABELLO，PINEDA BEGONA，TORMO EDUARDO，et al．The antitumor effect of metformin is mediated by miR-26a in breast cancer［J］．International Journal of Molecular Sciences，2016，17（8）：1298．
[8]CHIN-HSIAO TSENG．Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus［J］．Aging（Albany，NY．），2016，8（8）：1636-1649．
[9]OLIVIA LACROIX，COUTTENIER ALEXANDRA，VAES EVELIEN，et al．Impact of metformin on gastric adenocarcinoma survival：A Belgian population based study［J］．Cancer Epidemiology，2018，53：149-155．
[10]AUDRIUS DULSKAS，PATASIUS AUSVYDAS，LINKEVICIUTE-ULINSKIENE DONATA，et al．A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer［J］．Aging（Albany，NY．），2019，11（17）：7197-7205．
[11]WAI-SHAN CHUNG，LE PO-HSIEN，KUO CHIANG-JUNG，et al．Impact of metformin use on survival in patients with gastric cancer and diabetes mellitus following gastrectomy［J］．Cancers，2020，12（8）：2013．
[12]CHEN Xinhua，CHEN Yuehong，LI Tao，et al．Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy［J］．Chinese Journal of Cancer Research，2020，32（5）：631-644．
[13]MICHELLE-L BAGLIA，CUI Yong，ZHENG Tao，et al．Diabetes medication use in association with survival among patients of breast，colorectal，lung，or gastric cancer［J］．Cancer Research and Treatment，2019，51（2）：538-546．
[14]CHOONG-KUN LEE，JUNG MINKYU，JUNG INKYUNG，et al．Cumulative metformin use and its impact on survival in gastric cancer patients after gastrectomy［J］．Annals of Surgery，2016，263（1）：96-102．
[15]HO SEOK SEO，JUNG YOON-JU，KIM JI-HYUN，et al．The effect of metformin on prognosis in patients with locally advanced gastric cancer associated with type 2 diabetes mellitus［J］．American Journal of Clinical Oncology，2019，42（12）：909-917．
[16]王琳．二甲双胍对合并2型糖尿病的进展期胃癌根治术后患者预后的影响［D］．大连：大连医科大学，2018．
WANG L．Effect of metformin on prognosis of advanced gastric cancer patients after radical gastrectomy combined with type 2 diabetes mellitus［D］．Dalian:Dalian Medical University，2018．
[17]马国明，左卫微，梁磊，等．二甲双胍对进展期胃癌合并2型糖尿病患者术后生存的影响［J］．河北医药，2019，41（21）：3261-3264．
MA GM，ZUO WW，LIANG L，et al．Effects of metformin on survival after radical gastrectomy in patients with advanced gastric cancer complicated by type 2 diabetes mellitus［J］．Hebei Medical Journal，2019，41（21）：3261-3264．
[18]牛鹏云．二甲双胍对晚期胃癌合并糖尿病患者生存的影响［D］．郑州:郑州大学，2016．
NIU PY．Effect of metformin on survival of patients with advanced gastric cancer complicated with diabetes mellitu［D］．Zhengzhou:Zhengzhou University，2016．
[19]GALLAGHER EJ，LEROITH D．Diabetes，antihyperglycemic medications and cancer risk：smoke or fire［J］.Curr Opin Endocrinol Diabetes Obes，2013，20（5）：485-494.
[20]周寒丽，耿健雄，张华.二甲双胍抗肿瘤机制的研究进展［J］．现代肿瘤医学，2015,23（12）：1760-1763．
ZHOU HL,GENG JX,ZHANG H.Advance in the anti-tumor mechanism of metformin［J］．Modern Oncology，2015,23（12）：1760-1763．
[21]SEKINO N，KANO M，MATSUMOTO Y，et al.The antitumor effects of metformin on gastric cancer in vitro and on peritoneal metastasis［J］．Anticancer Research，2018，38（11）：6263-6269．
[22]SARAH COURTOIS，DURAN RAUL-V，GIRAUD JULIE，et al．Metformin targets gastric cancer stem cells［J］．European Journal of Cancer，2017，84：193-201．
[23]ZHANG Jing，WEN Liping，ZHOU Quan，et al．Preventative and therapeutic effects of metformin in gastric cancer：A new contribution of an old friend［J］．Cancer Manag Res，2020，12：8545-8554．
[24]ZHANG Huihui，GUO Xiuli．Combinational strategies of metformin and chemotherapy in cancers［J］．Cancer Chemotherapy and Pharmacology，2016，78（1）：13-26．
[25]SHUAI Y，LI C，ZHOU X．The effect of metformin on gastric cancer in patients with type 2 diabetes：a systematic review and Meta-analysis［J］．Clinical and Translational Oncology，2020，22（9）：1580-1590．
[26]KIM JH,HUH YJ，PARK S，et al．Multicenter results of long-limb bypass reconstruction after gastrectomy in patients with gastric cancer and type Ⅱ diabetes［J］．Asian J Surg，2020，43（1）：297-303．
备注/Memo
- 备注/Memo:
- 江苏省镇江市重点研发项目（社会发展）项目（编号：SH2018082）
